Over-The-Counter Drugs Market 2027 by Types, Application, Technology, Opportunities, End Users and Regions | The Insight Partners

Over-The-Counter Drugs Market to 2027 - Global Analysis and Forecasts By Product Type (Dermatology Products, Weight-loss or Dietary Products, Sleeping Aids, Gastrointestinal Products, Cough, Cold, and Flu Products, Analgesics, Vitamins, Mineral, and Supplements (VMS), Ophthalmic Products, Other Product Types); Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacy, Other Distribution Channels), and Geography

Report Code: TIPRE00005414 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
MARKET INTRODUCTION
Over-the-counter drugs are sold to the customer without a prescription of the doctor. They are typically used for minor health problems and are available at local pharmacies and shops. They are safe and effective when consumed according to the physician's directions. OTC drugs can be readily available in pharmacies and online health websites worldwide. Over the counter drugs are generally taken off the shelf. OTC drugs also include dietary supplements which are intended to deliver desired nutrients to the body to increase the quantity of an individual's diet.

MARKET DYNAMICS
The over-the-counter drug market is expected to grow exponentially in the forecast period owing to the factors such as improvement in lifestyle and aging of baby boomers, increasing penetration among emerging economies, favorable regulatory framework, and innovation in OTC products. Furthermore, the inclination of pharmaceutical companies towards OTC drugs from RX drugs is anticipated to offer significant growth opportunities in the market during the forecast period.

MARKET SCOPE
The "Global Over-The-Counter Drugs Market Analysis to 2027" is a specialized and in-depth study of the pharmaceutical industry with a particular focus on the global market trend analysis. The report aims to provide an overview of the over-the-counter drugs market with detailed market segmentation by product type, distribution channel, and geography. The global over-the-counter drugs market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading over-the-counter drugs market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION
The global over-the-counter drugs market is segmented on the basis of product type and distribution channel. Based on product type, the market is classified as dermatology products, weight-loss or dietary products, sleeping aids, gastrointestinal products, cough, cold, and flu products, analgesics, vitamins, mineral, and supplements (VMS), ophthalmic products, and other product types. Based on distribution channel, the market is divided as hospital pharmacies, retail pharmacies, online pharmacy and other distribution channels
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global over-the-counter drugs market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The over-the-counter drugs market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting over-the-counter drugs market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Over-the-counter drugs market in these regions.

MARKET PLAYERS
The reports cover key developments in the over-the-counter drugs market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from over-the-counter drugs market are anticipated to lucrative growth opportunities in the future with the rising demand for over-the-counter drugs market in the global market. Below mentioned is the list of few companies engaged in the Over-the-counter drugs market.

The report also includes the profiles of key over-the-counter drugs market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
  • Alkem Health Care
  • Bayer CropScience Limited
  • Cipla Inc.
  • GlaxoSmithKline plc.
  • Glenmark Pharmaceuticals Limited
  • Ipsen Pharma
  • Pfizer Inc.
  • Procter & Gamble
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd.
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Over-the-Counter Drugs Market - By Product Type
1.3.2 Over-the-Counter Drugs Market - By Distribution Channel
1.3.3 Over-the-Counter Drugs Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. OVER-THE-COUNTER DRUGS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. OVER-THE-COUNTER DRUGS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. OVER-THE-COUNTER DRUGS MARKET - GLOBAL MARKET ANALYSIS
6.1. OVER-THE-COUNTER DRUGS - GLOBAL MARKET OVERVIEW
6.2. OVER-THE-COUNTER DRUGS - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. OVER-THE-COUNTER DRUGS MARKET - REVENUE AND FORECASTS TO 2027 - PRODUCT TYPE
7.1. OVERVIEW
7.2. PRODUCT TYPE MARKET FORECASTS AND ANALYSIS
7.3. DERMATOLOGY PRODUCTS
7.3.1. Overview
7.3.2. Dermatology Products Market Forecast and Analysis
7.4. WEIGHT-LOSS OR DIETARY PRODUCTS
7.4.1. Overview
7.4.2. Weight-loss or Dietary Products Market Forecast and Analysis
7.5. SLEEPING AIDS
7.5.1. Overview
7.5.2. Sleeping Aids Market Forecast and Analysis
7.6. GASTROINTESTINAL PRODUCTS
7.6.1. Overview
7.6.2. Gastrointestinal Products Market Forecast and Analysis
7.7. COUGH, COLD, AND FLU PRODUCTS
7.7.1. Overview
7.7.2. Cough, Cold, and Flu Products Market Forecast and Analysis
7.8. ANALGESICS
7.8.1. Overview
7.8.2. Analgesics Market Forecast and Analysis
7.9. VITAMINS, MINERAL, AND SUPPLEMENTS (VMS)
7.9.1. Overview
7.9.2. Vitamins, Mineral, and Supplements (VMS) Market Forecast and Analysis
7.10. OPHTHALMIC PRODUCTS
7.10.1. Overview
7.10.2. Ophthalmic Products Market Forecast and Analysis
7.11. OTHER PRODUCT TYPES
7.11.1. Overview
7.11.2. Other Product Types Market Forecast and Analysis
8. OVER-THE-COUNTER DRUGS MARKET - REVENUE AND FORECASTS TO 2027 - DISTRIBUTION CHANNEL
8.1. OVERVIEW
8.2. DISTRIBUTION CHANNEL MARKET FORECASTS AND ANALYSIS
8.3. HOSPITAL PHARMACIES
8.3.1. Overview
8.3.2. Hospital Pharmacies Market Forecast and Analysis
8.4. RETAIL PHARMACIES
8.4.1. Overview
8.4.2. Retail Pharmacies Market Forecast and Analysis
8.5. ONLINE PHARMACY
8.5.1. Overview
8.5.2. Online Pharmacy Market Forecast and Analysis
8.6. OTHER DISTRIBUTION CHANNELS
8.6.1. Overview
8.6.2. Other Distribution Channels Market Forecast and Analysis
9. OVER-THE-COUNTER DRUGS MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Over-the-Counter Drugs Market Overview
9.1.2 North America Over-the-Counter Drugs Market Forecasts and Analysis
9.1.3 North America Over-the-Counter Drugs Market Forecasts and Analysis - By Product Type
9.1.4 North America Over-the-Counter Drugs Market Forecasts and Analysis - By Distribution Channel
9.1.5 North America Over-the-Counter Drugs Market Forecasts and Analysis - By Countries
9.1.5.1 United States Over-the-Counter Drugs Market
9.1.5.1.1 United States Over-the-Counter Drugs Market by Product Type
9.1.5.1.2 United States Over-the-Counter Drugs Market by Distribution Channel
9.1.5.2 Canada Over-the-Counter Drugs Market
9.1.5.2.1 Canada Over-the-Counter Drugs Market by Product Type
9.1.5.2.2 Canada Over-the-Counter Drugs Market by Distribution Channel
9.1.5.3 Mexico Over-the-Counter Drugs Market
9.1.5.3.1 Mexico Over-the-Counter Drugs Market by Product Type
9.1.5.3.2 Mexico Over-the-Counter Drugs Market by Distribution Channel
9.2. EUROPE
9.2.1 Europe Over-the-Counter Drugs Market Overview
9.2.2 Europe Over-the-Counter Drugs Market Forecasts and Analysis
9.2.3 Europe Over-the-Counter Drugs Market Forecasts and Analysis - By Product Type
9.2.4 Europe Over-the-Counter Drugs Market Forecasts and Analysis - By Distribution Channel
9.2.5 Europe Over-the-Counter Drugs Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Over-the-Counter Drugs Market
9.2.5.1.1 Germany Over-the-Counter Drugs Market by Product Type
9.2.5.1.2 Germany Over-the-Counter Drugs Market by Distribution Channel
9.2.5.2 France Over-the-Counter Drugs Market
9.2.5.2.1 France Over-the-Counter Drugs Market by Product Type
9.2.5.2.2 France Over-the-Counter Drugs Market by Distribution Channel
9.2.5.3 Italy Over-the-Counter Drugs Market
9.2.5.3.1 Italy Over-the-Counter Drugs Market by Product Type
9.2.5.3.2 Italy Over-the-Counter Drugs Market by Distribution Channel
9.2.5.4 Spain Over-the-Counter Drugs Market
9.2.5.4.1 Spain Over-the-Counter Drugs Market by Product Type
9.2.5.4.2 Spain Over-the-Counter Drugs Market by Distribution Channel
9.2.5.5 United Kingdom Over-the-Counter Drugs Market
9.2.5.5.1 United Kingdom Over-the-Counter Drugs Market by Product Type
9.2.5.5.2 United Kingdom Over-the-Counter Drugs Market by Distribution Channel
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Over-the-Counter Drugs Market Overview
9.3.2 Asia-Pacific Over-the-Counter Drugs Market Forecasts and Analysis
9.3.3 Asia-Pacific Over-the-Counter Drugs Market Forecasts and Analysis - By Product Type
9.3.4 Asia-Pacific Over-the-Counter Drugs Market Forecasts and Analysis - By Distribution Channel
9.3.5 Asia-Pacific Over-the-Counter Drugs Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Over-the-Counter Drugs Market
9.3.5.1.1 Australia Over-the-Counter Drugs Market by Product Type
9.3.5.1.2 Australia Over-the-Counter Drugs Market by Distribution Channel
9.3.5.2 China Over-the-Counter Drugs Market
9.3.5.2.1 China Over-the-Counter Drugs Market by Product Type
9.3.5.2.2 China Over-the-Counter Drugs Market by Distribution Channel
9.3.5.3 India Over-the-Counter Drugs Market
9.3.5.3.1 India Over-the-Counter Drugs Market by Product Type
9.3.5.3.2 India Over-the-Counter Drugs Market by Distribution Channel
9.3.5.4 Japan Over-the-Counter Drugs Market
9.3.5.4.1 Japan Over-the-Counter Drugs Market by Product Type
9.3.5.4.2 Japan Over-the-Counter Drugs Market by Distribution Channel
9.3.5.5 South Korea Over-the-Counter Drugs Market
9.3.5.5.1 South Korea Over-the-Counter Drugs Market by Product Type
9.3.5.5.2 South Korea Over-the-Counter Drugs Market by Distribution Channel
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Over-the-Counter Drugs Market Overview
9.4.2 Middle East and Africa Over-the-Counter Drugs Market Forecasts and Analysis
9.4.3 Middle East and Africa Over-the-Counter Drugs Market Forecasts and Analysis - By Product Type
9.4.4 Middle East and Africa Over-the-Counter Drugs Market Forecasts and Analysis - By Distribution Channel
9.4.5 Middle East and Africa Over-the-Counter Drugs Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Over-the-Counter Drugs Market
9.4.5.1.1 South Africa Over-the-Counter Drugs Market by Product Type
9.4.5.1.2 South Africa Over-the-Counter Drugs Market by Distribution Channel
9.4.5.2 Saudi Arabia Over-the-Counter Drugs Market
9.4.5.2.1 Saudi Arabia Over-the-Counter Drugs Market by Product Type
9.4.5.2.2 Saudi Arabia Over-the-Counter Drugs Market by Distribution Channel
9.4.5.3 U.A.E Over-the-Counter Drugs Market
9.4.5.3.1 U.A.E Over-the-Counter Drugs Market by Product Type
9.4.5.3.2 U.A.E Over-the-Counter Drugs Market by Distribution Channel
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Over-the-Counter Drugs Market Overview
9.5.2 South and Central America Over-the-Counter Drugs Market Forecasts and Analysis
9.5.3 South and Central America Over-the-Counter Drugs Market Forecasts and Analysis - By Product Type
9.5.4 South and Central America Over-the-Counter Drugs Market Forecasts and Analysis - By Distribution Channel
9.5.5 South and Central America Over-the-Counter Drugs Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Over-the-Counter Drugs Market
9.5.5.1.1 Brazil Over-the-Counter Drugs Market by Product Type
9.5.5.1.2 Brazil Over-the-Counter Drugs Market by Distribution Channel
9.5.5.2 Argentina Over-the-Counter Drugs Market
9.5.5.2.1 Argentina Over-the-Counter Drugs Market by Product Type
9.5.5.2.2 Argentina Over-the-Counter Drugs Market by Distribution Channel
10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
11. OVER-THE-COUNTER DRUGS MARKET, KEY COMPANY PROFILES
11.1. ALKEM HEALTH CARE
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. BAYER CROPSCIENCE LIMITED
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. CIPLA INC.
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. GLAXOSMITHKLINE PLC.
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. GLENMARK PHARMACEUTICALS LIMITED
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. IPSEN PHARMA
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. PFIZER INC.
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. PROCTER AND GAMBLE
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. SUN PHARMACEUTICAL INDUSTRIES LTD.
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. TEVA PHARMACEUTICAL INDUSTRIES LTD.
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments
12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
The List of Companies

1. Alkem Health Care
2. Bayer CropScience Limited
3. Cipla Inc.
4. GlaxoSmithKline plc.
5. Glenmark Pharmaceuticals Limited
6. Ipsen Pharma
7. Pfizer Inc.
8. Procter & Gamble
9. Sun Pharmaceutical Industries Ltd.
10. Teva Pharmaceutical Industries Ltd.
Select License Type
USD $3000
USD $4550
USD $6550
USD $8550

Free

20%

customization on Pre-Booking
Pre Book